Remove 2022 Remove FDA Remove Method Validation
article thumbnail

EMA publishes updated Q&A for ICH M10

European Pharmaceutical Review

The European Medicines Agency (EMA) has published an updated Q&A document regarding ICH M10 ‘Bioanalytical Method Validation and Study Sample Analysis’. The ICH M10 guideline provides recommendations on the validation of bioanalytical assays for chemical and biological drugs and their metabolites in biological matrices.

article thumbnail

CMC Requirements for New Drug Registration in Latin America

ISPE

ANVISA’s analytical method validation 15 and forced degradation 1 requirements are examples of those local regulations that bring additional technical requirements and make a Brazil dossier different from a US or EU dossier (both ICH member countries) and drive the divergence between harmonized global registration process. April 2004.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Streamlining Postapproval Submissions Using ICH Q12 & SCDM

ISPE

Mon, 08/29/2022 - 15:46. September / October 2022. 1 September 2022. In May 2021, the US Food and Drug Administration (FDA) published a draft industry guidance, ICH Q12: Implementation Considerations for FDA-Regulated Products. HC is expected to have full implementation of ICH Q12 by late 2022. Cauchon, PhD.

article thumbnail

CoP Leader Profiles: Roujian “RJ” Zhang

ISPE

My cousin, who now works for the FDA, has been studying malaria treatments for decades. “My grandfather died of pneumonia in the 1950s. Because he lived in China, he did not have access to penicillin, even though it was invented and being used to treat infections.